Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.

Madhavi V, Kent SJ, Stratov I.

Expert Rev Clin Immunol. 2012 Nov;8(8):767-74. doi: 10.1586/eci.12.74. Review.

PMID:
23167688
2.

Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.

Veillette M, Désormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, Finzi A.

J Virol. 2014 Mar;88(5):2633-44. doi: 10.1128/JVI.03230-13. Epub 2013 Dec 18.

3.

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.

Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G.

Curr HIV Res. 2013 Jul;11(5):378-87. Review.

4.

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.

Madhavi V, Wren LH, Center RJ, Gonelli C, Winnall WR, Parsons MS, Kramski M, Kent SJ, Stratov I.

AIDS. 2014 Aug 24;28(13):1859-70. doi: 10.1097/QAD.0000000000000310.

PMID:
24937308
5.

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.

Pollara J, Bonsignori M, Moody MA, Liu P, Alam SM, Hwang KK, Gurley TC, Kozink DM, Armand LC, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Robb ML, O'Connell RJ, Kim JH, Michael NL, Montefiori DC, Tomaras GD, Liao HX, Haynes BF, Ferrari G.

J Virol. 2014 Jul;88(14):7715-26. doi: 10.1128/JVI.00156-14. Epub 2014 May 7.

6.

Broadly neutralizing antibodies against HIV-1: templates for a vaccine.

van Gils MJ, Sanders RW.

Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Review.

7.

HIV-specific antibody immunity mediated through NK cells and monocytes.

Kramski M, Parsons MS, Stratov I, Kent SJ.

Curr HIV Res. 2013 Jul;11(5):388-406. Review.

PMID:
24191935
8.

HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity.

Wren L, Kent SJ.

Hum Vaccin. 2011 Apr;7(4):466-73. Epub 2011 Apr 1. Review.

PMID:
21389779
9.

RV144: old vs. new.

Weiner DB.

Hum Vaccin. 2010 Feb;6(2):159-61. Epub 2010 Feb 18. No abstract available.

PMID:
20431335
10.

Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.

Wren LH, Chung AW, Isitman G, Kelleher AD, Parsons MS, Amin J, Cooper DA; ADCC study collaboration investigators, Stratov I, Navis M, Kent SJ.

Immunology. 2013 Feb;138(2):116-23. doi: 10.1111/imm.12016.

11.

The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein.

Kramski M, Stratov I, Kent SJ.

AIDS. 2015 Jan 14;29(2):137-44. doi: 10.1097/QAD.0000000000000523. Review.

PMID:
25396265
12.

Obstacles to ideal anti-HIV antibody-dependent cellular cytotoxicity responses.

Wren LH, Stratov I, Kent SJ, Parsons MS.

Vaccine. 2013 Nov 12;31(47):5506-17. doi: 10.1016/j.vaccine.2013.08.035. Epub 2013 Aug 24. Review.

PMID:
23981432
13.

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.

Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G.

J Infect Dis. 1998 Feb;177(2):301-9.

14.

Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.

Kramski M, Lichtfuss GF, Navis M, Isitman G, Wren L, Rawlin G, Center RJ, Jaworowski A, Kent SJ, Purcell DF.

Eur J Immunol. 2012 Oct;42(10):2771-81. doi: 10.1002/eji.201242469. Epub 2012 Aug 28.

15.

A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.

Ferrantelli F, Maggiorella MT, Schiavoni I, Sernicola L, Olivieri E, Farcomeni S, Pavone-Cossut MR, Moretti S, Belli R, Collacchi B, Srivastava IK, Titti F, Cafaro A, Barnett SW, Ensoli B.

Vaccine. 2011 Apr 5;29(16):2918-32. doi: 10.1016/j.vaccine.2011.02.006. Epub 2011 Feb 21.

PMID:
21338681
16.

HIV vaccines: progress to date.

Munier CM, Andersen CR, Kelleher AD.

Drugs. 2011 Mar 5;71(4):387-414. doi: 10.2165/11585400-000000000-00000. Review.

PMID:
21395355
17.

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines.

Sharma VA, Kan E, Sun Y, Lian Y, Cisto J, Frasca V, Hilt S, Stamatatos L, Donnelly JJ, Ulmer JB, Barnett SW, Srivastava IK.

Virology. 2006 Aug 15;352(1):131-44. doi: 10.1016/j.virol.2006.04.030.

20.

Role of neutralizing antibodies in protective immunity against HIV.

Srivastava IK, Ulmer JB, Barnett SW.

Hum Vaccin. 2005 Mar-Apr;1(2):45-60. Epub 2005 Mar 17. Review.

PMID:
17038830
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk